Skip to main content

Table 1 Characteristics of patients with at least one UTI-related antimicrobial prescribed

From: E. coli bacteraemia and antimicrobial resistance following antimicrobial prescribing for urinary tract infection in the community

Antimicrobial Group

Amoxicillin, ciprofloxacin, amoxicillin/clavulanic acid, nitrofurantoin or trimethoprim

Nitrofurantoin or trimethoprim

Any

1,093,227 (100.0%)

752,225 (68.8%)

Gender

 Male

 Female

310,974 (28.4%)

782,253 (71.6%)

137,198 (18.2%)

615,027 (81.8%)

Age group

 16-34

 35-49

 50-64

  > 65

268,896 (24.6%)

242,173 (22.2%)

247,287 (22.6%)

334,871 (30.6%)

184,476 (24.5%)

152,857 (20.3%)

160,108 (21.3%)

254,784 (33.9%)

SIMD quintile (Q1 = Most Deprived, Q5 = Least Deprived)

 Q1

 Q2

 Q3

 Q4

 Q5

247,671 (22.8%)

232,451 (21.4%)

215,015 (19.8%)

198,832 (18.3%)

190,210 (17.5%)

169,301 (22.7%)

159,286 (21.4%)

147,401 (19.8%)

138,783 (18.6%)

131,272 (17.6%)

Long-term users of any antimicrobials

 Yes

85,036 (7.8%)

32,968 (4.4%)

 No

1,008,191 (92.2%)

719,257 (95.6%)

Treatment failures

 

195,184 (17.9%)

Trimethoprim: 72,705 (11.2%)

Nitrofurantoin: 38,625 (16.7%)

Number of antimicrobials received per patient

 1

 2

 3

 4

 5

491,315 (44.9%)

402,731 (36.8%)

144,671 (13.2%)

44,179 (4.0%)

10,331 (0.9%)

590,438 (54.0%)

161,787 (14.8%)